PharmTech News

Articles

TxCell’s new facilities are based in Sophia Antipolis, France, on the premises of GenBiotech.

TxCell Launches Industrialization Laboratories and Technology Transfer Academy

This marks the first time a biologic manufactured in China has been released for use in a clinical trial in Europe.

Prima BioMed’s IMP321 Enters Clinical Trials in Europe

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The pharma company revealed in a fourth quarter call that it will improve its cell-culture capabilities by focusing on the use of naïve, highly proliferative cells to manufacture its CAR-T drug candidate.

Kite Pharma Stresses Importance of Cell-Culturing Techniques

Company representatives said a bulk of the increase was due to strong sales of its bioprocessing products.

Repligen Reports a Revenue Increase of 45%

The collaboration is part of Innovate UK’s competition for the development of regenerative medicines.

Cobra Biologics and CPI Collaborate on AAV Manufacturing Platform

Under the agreement, Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou’s intellectual property.

Caribou Biosciences and IDT Enter into Non-Exclusive License Agreement for CRISPR-Cas9 Reagents

Researchers discovered more than 300 antibodies that reacted with the Ebola virus’s surface glycoprotein and could be used to neutralize many strains of the virus.

Study Reveals New Group of Antibodies to Fight Ebola

Sandoz filed a petition with the US Supreme Court to review a Federal Circuit Court’s July 2015 judgment of the Biologics Price Competition and Innovation Act (BPCIA). The pharmaceutical company filed the writ of certiorari with the court on Feb.

Sandoz Petitions Supreme Court to Review Federal Circuit Court Decision on BPCIA

FDA fast-tracked the monoclonal antibody based on early clinical data from a Phase I trial.

Durvalumab Receives Breakthrough Therapy Status

Wyeth reaches agreement in principle to resolve Medicaid drug rebate claims for 2001-2006 period for Protonix.

Bio/Pharma News